• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主内有利于 SARS-CoV-2 的病毒前体和抗病毒因子。

Host proviral and antiviral factors for SARS-CoV-2.

机构信息

Department of Pathogen Biology, School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.

Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.

出版信息

Virus Genes. 2021 Dec;57(6):475-488. doi: 10.1007/s11262-021-01869-2. Epub 2021 Sep 11.

DOI:10.1007/s11262-021-01869-2
PMID:34510331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8435179/
Abstract

Throughout the viral life cycle, interplays between cellular host factors and virus determine the infectious capacity of the virus. The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a great threat to human life and health. Extensive studies identified a number of host proviral and antiviral factors for SARS-CoV-2. In this review, we summarize the current understanding of the interplay between SARS-CoV-2 and cellular factors during virus entry and replication. Our review will highlight the future direction of study on the infection and pathogenesis of SARS-CoV-2, as well as novel therapeutic strategies and effective antiviral targets for COVID-19.

摘要

在整个病毒生命周期中,细胞宿主因素与病毒之间的相互作用决定了病毒的感染能力。由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)大流行对人类生命和健康构成了巨大威胁。广泛的研究确定了许多宿主促进病毒复制和抗病毒的因素。在这篇综述中,我们总结了目前对 SARS-CoV-2 进入细胞和复制过程中与细胞因子相互作用的理解。我们的综述将突出 SARS-CoV-2 感染和发病机制的未来研究方向,以及 COVID-19 的新型治疗策略和有效的抗病毒靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/908e/8435179/e81d8b4f27d4/11262_2021_1869_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/908e/8435179/e81d8b4f27d4/11262_2021_1869_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/908e/8435179/e81d8b4f27d4/11262_2021_1869_Fig1_HTML.jpg

相似文献

1
Host proviral and antiviral factors for SARS-CoV-2.宿主内有利于 SARS-CoV-2 的病毒前体和抗病毒因子。
Virus Genes. 2021 Dec;57(6):475-488. doi: 10.1007/s11262-021-01869-2. Epub 2021 Sep 11.
2
Cellular host factors for SARS-CoV-2 infection.SARS-CoV-2 感染的细胞宿主因子。
Nat Microbiol. 2021 Oct;6(10):1219-1232. doi: 10.1038/s41564-021-00958-0. Epub 2021 Sep 1.
3
Coronavirus biology and replication: implications for SARS-CoV-2.冠状病毒的生物学与复制:对 SARS-CoV-2 的启示。
Nat Rev Microbiol. 2021 Mar;19(3):155-170. doi: 10.1038/s41579-020-00468-6. Epub 2020 Oct 28.
4
Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies.理解严重急性呼吸综合征冠状病毒 2 复制以设计有效的药物联合治疗方案。
Intervirology. 2020;63(1-6):2-9. doi: 10.1159/000512141. Epub 2020 Oct 23.
5
Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.人类血管紧张素转换酶2(ACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)在决定新型冠状病毒肺炎(COVID-19)宿主-病原体相互作用中的作用。
J Genet. 2021;100(1). doi: 10.1007/s12041-021-01262-w.
6
SARS-CoV 2; Possible alternative virus receptors and pathophysiological determinants.SARS-CoV-2;可能的替代病毒受体和病理生理决定因素。
Med Hypotheses. 2021 Jan;146:110368. doi: 10.1016/j.mehy.2020.110368. Epub 2020 Nov 6.
7
Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.理解单个 SARS-CoV-2 蛋白以针对 COVID-19 开发靶向药物。
Mol Cell Biol. 2021 Aug 24;41(9):e0018521. doi: 10.1128/MCB.00185-21.
8
The viral protein fragment theory of COVID-19 pathogenesis.新冠病毒发病机制的病毒蛋白片段理论。
Med Hypotheses. 2020 Nov;144:110267. doi: 10.1016/j.mehy.2020.110267. Epub 2020 Sep 11.
9
A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses.人类冠状病毒受体综述:带冠状病毒的宿主细胞靶标
Molecules. 2021 Oct 26;26(21):6455. doi: 10.3390/molecules26216455.
10
Membrane remodeling and trafficking piloted by SARS-CoV-2.由 SARS-CoV-2 驱动的膜重塑和运输。
Trends Cell Biol. 2024 Sep;34(9):785-800. doi: 10.1016/j.tcb.2023.12.006. Epub 2024 Jan 22.

引用本文的文献

1
Glycosylphosphatidylinositol biosynthesis functions as a conserved host defense pathway against coronaviruses via regulation of LY6E.糖基磷脂酰肌醇生物合成通过对LY6E的调控,作为一种针对冠状病毒的保守宿主防御途径发挥作用。
PLoS Pathog. 2025 Sep 3;21(9):e1013441. doi: 10.1371/journal.ppat.1013441. eCollection 2025 Sep.
2
Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication.输出蛋白1/ XPO1核输出途径抑制对冠状病毒复制的影响。
Viruses. 2025 Feb 18;17(2):284. doi: 10.3390/v17020284.
3
SARS-CoV-2 mechanisms of cell tropism in various organs considering host factors.

本文引用的文献

1
Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication.VPS34 和脂肪酸代谢抑制剂抑制 SARS-CoV-2 复制。
Cell Rep. 2021 Aug 3;36(5):109479. doi: 10.1016/j.celrep.2021.109479. Epub 2021 Jul 20.
2
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2.全基因组 CRISPR 筛选鉴定 TMEM106B 为 SARS-CoV-2 的前病毒宿主因子。
Nat Genet. 2021 Apr;53(4):435-444. doi: 10.1038/s41588-021-00805-2. Epub 2021 Mar 8.
3
A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry.
考虑宿主因素的SARS-CoV-2在各器官中的细胞嗜性机制。
Heliyon. 2024 Feb 20;10(4):e26577. doi: 10.1016/j.heliyon.2024.e26577. eCollection 2024 Feb 29.
4
Modulations in the host cell proteome by the hantavirus nucleocapsid protein.汉坦病毒核衣壳蛋白对宿主细胞蛋白质组的调节。
PLoS Pathog. 2024 Jan 8;20(1):e1011925. doi: 10.1371/journal.ppat.1011925. eCollection 2024 Jan.
5
Xuanfei Baidu decoction in the treatment of coronavirus disease 2019 (COVID-19): Efficacy and potential mechanisms.宣肺败毒汤治疗新型冠状病毒肺炎(COVID-19):疗效与潜在机制
Heliyon. 2023 Aug 19;9(9):e19163. doi: 10.1016/j.heliyon.2023.e19163. eCollection 2023 Sep.
6
The Isolation and In Vitro Differentiation of Primary Fetal Baboon Tracheal Epithelial Cells for the Study of SARS-CoV-2 Host-Virus Interactions.用于研究 SARS-CoV-2 宿主-病毒相互作用的原代狒狒胎气管上皮细胞的分离和体外分化。
Viruses. 2023 Mar 28;15(4):862. doi: 10.3390/v15040862.
7
The potential role of scavenger receptor B type I (SR-BI) in SARS-CoV-2 infection.清道夫受体 B 型 I(SR-BI)在 SARS-CoV-2 感染中的潜在作用。
Immun Inflamm Dis. 2023 Apr;11(4):e786. doi: 10.1002/iid3.786.
8
Effect of exportin 1/XPO1 nuclear export pathway inhibition on coronavirus replication.输出蛋白1/XPO1核输出途径抑制对冠状病毒复制的影响。
bioRxiv. 2024 Dec 11:2023.02.09.527884. doi: 10.1101/2023.02.09.527884.
9
Features of Pathobiology and Clinical Translation of Approved Treatments for Coronavirus Disease 2019.获批治疗 2019 冠状病毒病的病理生物学和临床转化特征。
Intervirology. 2022;65(3):119-133. doi: 10.1159/000520234. Epub 2021 Oct 25.
全基因组 CRISPR 筛选鉴定调控 SARS-CoV-2 进入的宿主因子。
Nat Commun. 2021 Feb 11;12(1):961. doi: 10.1038/s41467-021-21213-4.
4
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.AXL 是 SARS-CoV-2 的候选受体,能促进肺和支气管上皮细胞的感染。
Cell Res. 2021 Feb;31(2):126-140. doi: 10.1038/s41422-020-00460-y. Epub 2021 Jan 8.
5
Host and viral determinants for efficient SARS-CoV-2 infection of the human lung.宿主和病毒因素决定人肺高效感染 SARS-CoV-2。
Nat Commun. 2021 Jan 8;12(1):134. doi: 10.1038/s41467-020-20457-w.
6
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks.基于全基因组鉴定 SARS-CoV-2 和泛冠状病毒宿主因子网络。
Cell. 2021 Jan 7;184(1):120-132.e14. doi: 10.1016/j.cell.2020.12.006. Epub 2020 Dec 9.
7
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors.对 SARS-CoV-2 宿主蛋白相互作用组的功能研究鉴定了独特和共享的冠状病毒宿主因子。
Cell Host Microbe. 2021 Feb 10;29(2):267-280.e5. doi: 10.1016/j.chom.2020.12.009. Epub 2020 Dec 16.
8
The SARS-CoV-2 RNA-protein interactome in infected human cells.感染人类细胞中的 SARS-CoV-2 RNA-蛋白相互作用组。
Nat Microbiol. 2021 Mar;6(3):339-353. doi: 10.1038/s41564-020-00846-z. Epub 2020 Dec 21.
9
Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.遗传筛选鉴定 SARS-CoV-2 和普通感冒冠状病毒的宿主因子。
Cell. 2021 Jan 7;184(1):106-119.e14. doi: 10.1016/j.cell.2020.12.004. Epub 2020 Dec 9.
10
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.CD147-刺突蛋白是 SARS-CoV-2 感染宿主细胞的新途径。
Signal Transduct Target Ther. 2020 Dec 4;5(1):283. doi: 10.1038/s41392-020-00426-x.